BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report) - Stock analysts at Leerink Partnrs lowered their Q1 2025 earnings estimates for BrightSpring Health Services in a report issued on Tuesday, January 28th. Leerink Partnrs analyst W. Mayo now anticipates that the company will post earnings per share of $0.07 for the quarter, down from their prior forecast of $0.16. The consensus estimate for BrightSpring Health Services' current full-year earnings is $0.59 per share. Leerink Partnrs also issued estimates for BrightSpring Health Services' Q2 2025 earnings at $0.12 EPS, Q3 2025 earnings at $0.11 EPS, Q4 2025 earnings at $0.16 EPS, FY2025 earnings at $0.46 EPS, Q1 2026 earnings at $0.13 EPS, Q2 2026 earnings at $0.19 EPS, Q3 2026 earnings at $0.15 EPS, Q4 2026 earnings at $0.22 EPS, FY2026 earnings at $0.69 EPS, FY2027 earnings at $0.90 EPS and FY2028 earnings at $1.16 EPS.
BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last issued its quarterly earnings data on Friday, November 1st. The company reported $0.11 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.18 by ($0.07). The business had revenue of $2.91 billion for the quarter, compared to analyst estimates of $2.72 billion. BrightSpring Health Services had a negative net margin of 0.38% and a positive return on equity of 4.16%. The company's quarterly revenue was up 28.8% compared to the same quarter last year.
Other research analysts have also issued reports about the stock. Morgan Stanley raised their price target on shares of BrightSpring Health Services from $19.00 to $20.00 and gave the company an "overweight" rating in a research report on Tuesday, December 17th. Mizuho raised their price target on shares of BrightSpring Health Services from $17.00 to $20.00 and gave the company an "outperform" rating in a research report on Monday, November 4th. Bank of America raised their price target on shares of BrightSpring Health Services from $19.00 to $21.00 and gave the company a "buy" rating in a research report on Wednesday, December 11th. Wells Fargo & Company raised their price target on shares of BrightSpring Health Services from $17.00 to $21.00 and gave the company an "overweight" rating in a research report on Wednesday, November 27th. Finally, CJS Securities initiated coverage on shares of BrightSpring Health Services in a research report on Thursday, December 12th. They set an "outperform" rating and a $27.00 price target on the stock. One equities research analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $19.42.
Check Out Our Latest Analysis on BTSG
BrightSpring Health Services Stock Up 0.5 %
Shares of BTSG traded up $0.12 during trading hours on Thursday, reaching $23.72. 1,418,628 shares of the stock traded hands, compared to its average volume of 1,674,525. The company has a current ratio of 1.35, a quick ratio of 0.97 and a debt-to-equity ratio of 1.63. The stock has a fifty day simple moving average of $18.82 and a 200 day simple moving average of $16.02. BrightSpring Health Services has a 52 week low of $7.85 and a 52 week high of $24.82. The company has a market cap of $4.13 billion and a price-to-earnings ratio of -91.23.
Hedge Funds Weigh In On BrightSpring Health Services
Several large investors have recently modified their holdings of the business. BNP Paribas Financial Markets increased its stake in shares of BrightSpring Health Services by 5.0% in the third quarter. BNP Paribas Financial Markets now owns 21,329 shares of the company's stock worth $313,000 after purchasing an additional 1,011 shares in the last quarter. Rhumbline Advisers grew its stake in BrightSpring Health Services by 1.5% during the fourth quarter. Rhumbline Advisers now owns 73,583 shares of the company's stock valued at $1,253,000 after acquiring an additional 1,118 shares in the last quarter. R Squared Ltd purchased a new position in BrightSpring Health Services during the fourth quarter valued at approximately $74,000. Charles Schwab Investment Management Inc. grew its stake in BrightSpring Health Services by 1.5% during the third quarter. Charles Schwab Investment Management Inc. now owns 440,335 shares of the company's stock valued at $6,464,000 after acquiring an additional 6,326 shares in the last quarter. Finally, Geode Capital Management LLC grew its stake in BrightSpring Health Services by 0.6% during the third quarter. Geode Capital Management LLC now owns 1,304,214 shares of the company's stock valued at $19,150,000 after acquiring an additional 7,750 shares in the last quarter.
BrightSpring Health Services Company Profile
(
Get Free Report)
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
See Also
Before you consider BrightSpring Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BrightSpring Health Services wasn't on the list.
While BrightSpring Health Services currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
